drugset / Trial / NCT03028116
Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine
Phase 1
Completed
44 enrolled
Research Institute for Biological Safety Problems
Asfendiyarov Kazakh National Medical University · collabResearch Institute of Influenza, Russia · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The study is a single centre, phase I, double-blind, randomized, placebo-controlled trial that explored the safety and immunogenicity of single dose a allantoic split inactivated seasonal influenza vaccine in healthy adults.
Timeline
- Start
- 2016-05
- Primary completion
- 2016-06
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Influenza Virus Vaccine | Vaccine | — | — |